TY - JOUR
T1 - Circulating exosomal microRNA-203 is associated with metastasis possibly via inducing tumor-associated macrophages in colorectal cancer
AU - Takano, Yuki
AU - Masuda, Takaaki
AU - Iinuma, Hisae
AU - Yamaguchi, Rui
AU - Sato, Kuniaki
AU - Tobo, Taro
AU - Hirata, Hidenari
AU - Kuroda, Yohsuke
AU - Nambara, Sho
AU - Hayashi, Naoki
AU - Iguchi, Tomohiro
AU - Ito, Shuhei
AU - Eguchi, Hidetoshi
AU - Ochiya, Takahiro
AU - Yanaga, Katsuhiko
AU - Miyano, Satoru
AU - Mimori, Koshi
N1 - Funding Information:
We thank M. Oshiumi, M. Uto, K. Oda, M. Kasagi, S. Sakuma, N. Mishima and T. Kawano for their technical assistance, and Dr. Tyler Lahusen for English proofreading. This work was supported in part by the following grants and foundations: Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Science Research (Grant Numbers 16K07177, 16K10543, 16K10397, 16K19197, 16K19107, 16H01576, 26461980 and 26293303); OITA Cancer Research Foundation; Daiwa Securities Health Foundation; Grant-in-Aid for Scientific Research on Innovative Areas (15H0912); Priority Issue on Post-K computer (hp170227) (hp170227, hp160219); JSPS KAKENHI (15H05707).
Publisher Copyright:
© Takano et al.
PY - 2017
Y1 - 2017
N2 - A primary tumor can create a premetastatic niche in distant organs to facilitate the development of metastasis. The mechanism by which tumor cells communicate with host cells to develop premetastatic niches is unclear. We focused on the role of microRNA (miR) signaling in promoting metastasis. Here, we identified miR-203 as a signaling molecule between tumors and monocytes in metastatic colorectal cancer (CRC) patients. Notably, high expression of serum exosomal miR-203, a major form in circulation, was associated with distant metastasis and an independent poor prognostic factor, whereas low expression in tumor tissues was a poor prognostic factor in CRC patients. We also found that exosomes carrying miR-203 from CRC cells were incorporated into monocytes and miR-203 could promote the expression of M2 markers in vitro, suggesting miR-203 promoted the differentiation of monocytes to M2-tumor-associated macrophages (TAMs). In a xenograft mouse model, miR-203-transfected CRC cells developed more liver metastasis compared to control cells. In conclusion, serum exosomal miR-203 expression is a novel biomarker for predicting metastasis, possibly via promoting the differentiation of monocytes to M2-TAMs in CRC. Furthermore, we propose the concept of site-dependent functions for miR-203 in tumor progression.
AB - A primary tumor can create a premetastatic niche in distant organs to facilitate the development of metastasis. The mechanism by which tumor cells communicate with host cells to develop premetastatic niches is unclear. We focused on the role of microRNA (miR) signaling in promoting metastasis. Here, we identified miR-203 as a signaling molecule between tumors and monocytes in metastatic colorectal cancer (CRC) patients. Notably, high expression of serum exosomal miR-203, a major form in circulation, was associated with distant metastasis and an independent poor prognostic factor, whereas low expression in tumor tissues was a poor prognostic factor in CRC patients. We also found that exosomes carrying miR-203 from CRC cells were incorporated into monocytes and miR-203 could promote the expression of M2 markers in vitro, suggesting miR-203 promoted the differentiation of monocytes to M2-tumor-associated macrophages (TAMs). In a xenograft mouse model, miR-203-transfected CRC cells developed more liver metastasis compared to control cells. In conclusion, serum exosomal miR-203 expression is a novel biomarker for predicting metastasis, possibly via promoting the differentiation of monocytes to M2-TAMs in CRC. Furthermore, we propose the concept of site-dependent functions for miR-203 in tumor progression.
UR - http://www.scopus.com/inward/record.url?scp=85029450805&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85029450805&partnerID=8YFLogxK
U2 - 10.18632/oncotarget.20009
DO - 10.18632/oncotarget.20009
M3 - Article
C2 - 29108252
AN - SCOPUS:85029450805
SN - 1949-2553
VL - 8
SP - 78598
EP - 78613
JO - Oncotarget
JF - Oncotarget
IS - 45
ER -